Actuate Therapeutics stock gets FDA clearance for elraglusib trial
1 source
·5h ago
← All stories
Actuate Therapeutics
Pharmaceutical Preparations · US
- HQ
- FORT WORTH, TX
- Industry
- Pharmaceutical Preparations
- Country
- US
In the news · 1
Recent filings
- 14 Aug 2026 10-Q Q2 2026
Actual SEC filing dates from EDGAR.
More in Healthcare